Submitted by Anonymous (not verified) on 17 July 2025 - 14:08
Orphan designation: Felzartamab Treatment of primary IgA nephropathy, 11/11/2024 Positive
Source:
Orphan designation: Felzartamab Treatment of primary IgA nephropathy, 11/11/2024 Positive